Related Experiment Video
Updated: Aug 13, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Mirtazapene: a noradrenergic and specific serotonergic antidepressant
This clinical update reviews the antidepressant mirtazapine, detailing its proven benefits, safety profile, and potential side effects for medical professionals.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Medicine
Background:
- Mirtazapine is an antidepressant medication.
- It belongs to the class of noradrenergic and specific serotonergic antidepressants (NaSSAs).
- This review is part of a series on medication advances.
Purpose of the Study:
- To summarize the established benefits of mirtazapine.
- To review the safety profile of mirtazapine.
- To outline the clinical side effects associated with mirtazapine.
Main Methods:
- Literature review of established data.
- Summary of clinical trial findings.
- Clinical expertise synthesis.
Main Results:
- Mirtazapine demonstrates significant efficacy in treating depression.
- The safety profile is generally favorable with manageable side effects.
- Common side effects include somnolence and weight gain.
Conclusions:
- Mirtazapine is a valuable therapeutic option for depression.
- Understanding its benefits and side effects is crucial for effective clinical use.
- Further research may explore novel applications or formulations.
More Related Videos
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists